Valuation: Illumina, Inc.

Market Cap 31.45B 28.02B 25.63B 23.35B 44B 2,972B 45.19B 308B 123B 1,574B 118B 116B 4,967B P/E 2026 *
40.9x
P/E 2027 * 34.7x
Enterprise Value 31.37B 27.95B 25.57B 23.28B 43.89B 2,964B 45.07B 307B 123B 1,570B 118B 115B 4,954B EV / Sales 2026 *
6.77x
EV / Sales 2027 * 6.13x
Free-Float
74.99%
Yield 2026 *
-
Yield 2027 * -
1 day-8.18%
1 week-28.29%
Current month-11.86%
1 month-29.18%
3 months+4.07%
6 months+49.56%
Current year+58.58%
1 week 205
Extreme 205
244.05
1 month 205
Extreme 205
294.2
Current year 112.65
Extreme 112.65
309.34
1 year 112.65
Extreme 112.65
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
05/10/26 Tax

Chief Executive Officer

-1,303 0.0009%
30/09/26
Corvex Management LP
OtherCompany 0 0% -
30/09/26 Free

Director

113 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-8.18%-28.29%+69.88%+77.90% 31.45B
-4.14%-4.55%+19.26%+48.86% 251B
-2.82%+4.40%-14.59%+68.22% 162B
-3.66%-4.49%+6.66%+14.39% 159B
-2.58%+4.57%-54.86%-15.02% 64.7B
+1.46%+6.76%+21.70%+50.32% 57.97B
-2.48%+2.21%-1.02%-7.84% 56.21B
-0.17%-0.08%+5.03%+59.36% 50.21B
-3.04%-5.17%+17.04%+57.57% 48.43B
-3.11%-5.62%+21.81%+73.93% 44.51B
Average -2.60%-2.12%+9.09%+42.77% 92.6B
Weighted average by Cap. -2.61%-0.77%+5.85%+41.73%

Financials

2026 *2027 *
Net sales 4.63B 4.13B 3.78B 3.44B 6.48B 438B 6.66B 45.36B 18.14B 232B 17.39B 17.01B 732B 4.95B 4.41B 4.04B 3.68B 6.93B 468B 7.12B 48.49B 19.39B 248B 18.59B 18.19B 782B
Net income 798M 711M 650M 592M 1.12B 75.42B 1.15B 7.81B 3.12B 39.94B 3B 2.93B 126B 920M 820M 750M 683M 1.29B 86.94B 1.32B 9.01B 3.6B 46.04B 3.45B 3.38B 145B
Net Debt -83.57M -74.47M -68.11M -62.03M -117M -7.9B -120M -818M -327M -4.18B -314M -307M -13.2B -1.1B -983M -899M -819M -1.54B -104B -1.58B -10.8B -4.32B -55.2B -4.14B -4.05B -174B
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
06/11/26 $213.88 +2.83% 428,605
05/11/26 $208.00 -8.18% 4,236,753
04/11/26 $226.54 -4.90% 3,036,411
03/11/26 $238.21 +5.13% 2,232,175
02/11/26 $226.58 -3.99% 2,925,989
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
208.00USD
Average target price
262.35USD
Spread / Average Target
+26.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Illumina, Inc.
  1. Stock Market
  2. Stocks
  3. ILMN Stock